Salazar, Nurhaniza T.

HRN: 26-63-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2025
CEFTRIAXONE 1G (VIAL)
02/04/2025
02/18/2025
IV
2G
OD X7days
Multiple Physical Injuries Sec To MVA
Waiting Final Action 
02/11/2025
MUPIROCIN 2%, 15G (TUBE)
02/11/2025
02/18/2025
TOPICAL
Apply Thinly On Affected Areas
Bid
Wound
Waiting Final Action 
02/20/2025
CEFTRIAXONE 1G (VIAL)
02/20/2025
02/27/2025
IV
2g
Q 24H
S/P ORIF Clavicle
Waiting Final Action 
02/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/21/2025
02/27/2025
IV
180mg
Q8h
Acute Bacterial Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: